Literature DB >> 17574656

Vasculogenesis and angiogenesis in the early human placenta.

Ramazan Demir1, Yasemin Seval, Berthold Huppertz.   

Abstract

Vasculogenesis and angiogenesis are two consecutive processes during blood vessel development in the human placenta. While vasculogenesis, which is the formation of first blood vessels, is achieved by differentiation of pluripotent mesenchymal cells into haemangiogenic stem cells. The subsequent step, angiogenesis, is characterized by development of new vessels from already existing vessels. In this review, we aim to give an overview of vasculogenesis and angiogenesis during the first trimester of human placental development. Recent studies have shown that at the very early stages of placental development, cytotrophoblasts trigger vasculogenesis and angiogenesis, whereas as pregnancy progresses Hofbauer and stromal cells take over the task of triggering blood vessel development. Important growth factors in this scenario are the vascular endothelial growth factor (VEGF) family and their receptors, as well as Tie-1 and Tie-2. This review depicts the molecular and morphological steps of vasculogenesis and angiogenesis, which can give further insights into human placental development and maturation disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574656     DOI: 10.1016/j.acthis.2007.02.008

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  59 in total

1.  VEGF and VEGFR1 levels in different regions of the normal and preeclampsia placentae.

Authors:  Akriti S Sahay; Anjali T Jadhav; Deepali P Sundrani; Girija N Wagh; Savita S Mehendale; Preeti Chavan-Gautam; Sadhana R Joshi
Journal:  Mol Cell Biochem       Date:  2017-08-02       Impact factor: 3.396

2.  Biomimetic poly(ethylene glycol)-based hydrogels as scaffolds for inducing endothelial adhesion and capillary-like network formation.

Authors:  Junmin Zhu; Ping He; Lin Lin; Derek R Jones; Roger E Marchant
Journal:  Biomacromolecules       Date:  2012-02-22       Impact factor: 6.988

3.  Amphiphilic suramin dissolves Matrigel, causing an 'inhibition' artefact within in vitro angiogenesis assays.

Authors:  Natalie L Prigozhina; Andrew J Heisel; Jordan R Seldeen; Nicholas D P Cosford; Jeffrey H Price
Journal:  Int J Exp Pathol       Date:  2013-09-02       Impact factor: 1.925

4.  Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes.

Authors:  Zeynep Alpay Savasan; Roberto Romero; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Sun Kwon Kim; Shali Mazaki-Tovi; Edi Vaisbuch; Pooja Mittal; Giovanna Ogge; Ichchha Madan; Zhong Dong; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

Review 5.  Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes.

Authors:  Zowi R Huinen; Elisabeth J M Huijbers; Judy R van Beijnum; Patrycja Nowak-Sliwinska; Arjan W Griffioen
Journal:  Nat Rev Clin Oncol       Date:  2021-04-08       Impact factor: 66.675

6.  Mutant-specific gene expression profiling identifies SRY-related HMG box 11b (SOX11b) as a novel regulator of vascular development in zebrafish.

Authors:  Christopher E Schmitt; Melissa J Woolls; Suk-Won Jin
Journal:  Mol Cells       Date:  2013-02-21       Impact factor: 5.034

7.  Protein tyrosine phosphatase interacting protein 51 (PTPIP51) mRNA expression and localization and its in vitro interacting partner protein tyrosine phosphatase 1B (PTP1B) in human placenta of the first, second, and third trimester.

Authors:  Albrecht Stenzinger; David Märker; Philipp Koch; Jens Hoffmann; Nelli Baal; Klaus Steger; Monika Wimmer
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

8.  Modeling the variability of shapes of a human placenta.

Authors:  M Yampolsky; C M Salafia; O Shlakhter; D Haas; B Eucker; J Thorp
Journal:  Placenta       Date:  2008-07-31       Impact factor: 3.481

9.  Angiogenesis in differentiated placental multipotent mesenchymal stromal cells is dependent on integrin alpha5beta1.

Authors:  Ming-Yi Lee; Jian-Pei Huang; Yi-Yung Chen; John D Aplin; Yi-Hsin Wu; Chia-Yu Chen; Pei-Chun Chen; Chie-Pein Chen
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

10.  Molecular characterization of EG-VEGF-mediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells.

Authors:  Sophie Brouillet; Pascale Hoffmann; Mohamed Benharouga; Aude Salomon; Jean-Patrick Schaal; Jean-Jacques Feige; Nadia Alfaidy
Journal:  Mol Biol Cell       Date:  2010-06-29       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.